Company Overview of River Vision Development Corp.
River Vision Development Corp. develops RV001, a protein therapy for the treatment of Graves’ Orbitopathy (GO). The company was founded in 2011 and is based in New York, New York.
One Rockefeller Plaza
New York, NY 10020
Founded in 2011
Key Executives for River Vision Development Corp.
River Vision Development Corp. Key Developments
Similar Private Companies By Industry
|TriLink BioTechnologies, Inc.||United States|
|FORMA Therapeutics, Inc.||United States|
|Lifeline Technologies, Inc.||United States|
Recent Private Companies Transactions
January 7, 2014
To contact River Vision Development Corp., please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.